Fibrogen announces leadership transition

Appoints thane wettig as interim chief executive officer wettig succeeds enrique conterno and brings over 30 years of global pharmaceutical leadership san francisco, july 25, 2023 (globe newswire) -- fibrogen, inc. (nasdaq: fgen), today announced the appointment of thane wettig as the company's interim chief executive officer effective as of july 23, 2023. mr. wettig has served as fibrogen's chief commercial officer and a key member of the senior leadership team since june 2020.
FGEN Ratings Summary
FGEN Quant Ranking